Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer.
about
Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patients.Treatment for recurrent ovarian cancer-at first relapse.Local intracerebral administration of Paclitaxel with the paclimer delivery system: toxicity study in a canine model.Emerging drugs for ovarian cancer.Optimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan?A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens.Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGelA review of iniparib in ovarian cancer.Role of gemcitabine in the treatment of ovarian cancer.Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer.
P2860
Q33371474-8C2C13D4-C56B-4D1E-A009-855864BAA94BQ33570711-915D4050-1F61-4EB5-A129-0F6F2AB4BDC4Q35127225-67BFC840-0DEF-4819-B832-660DE4229CB2Q36150652-3E64740E-4F50-45B6-BECB-532F2233CCF2Q36488198-8702324C-4688-4349-86DB-D24EBF75AEF7Q36610752-792B903F-176B-4EB3-90BF-36A9F01CB6C0Q37113732-FBF3E5F6-785B-4AFB-88E1-81969E3A50E7Q37689187-781D5852-2CBB-4CA1-8E88-F7C625C52590Q38080153-EECBC172-C5E8-4B5A-90C8-F29BA2BF7B4EQ43267035-D28EB5F5-AFD2-4AAE-810C-5EA5DC89E3C3Q46623057-03C89C5A-7376-4D62-8E9E-35B762541530
P2860
Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Phase II study of gemcitabine ...... inum-resistant ovarian cancer.
@ast
Phase II study of gemcitabine ...... inum-resistant ovarian cancer.
@en
type
label
Phase II study of gemcitabine ...... inum-resistant ovarian cancer.
@ast
Phase II study of gemcitabine ...... inum-resistant ovarian cancer.
@en
prefLabel
Phase II study of gemcitabine ...... inum-resistant ovarian cancer.
@ast
Phase II study of gemcitabine ...... inum-resistant ovarian cancer.
@en
P2093
P1433
P1476
Phase II study of gemcitabine ...... inum-resistant ovarian cancer.
@en
P2093
Agustin A Garcia
Anne O'Meara
Ashim Bahador
Dae-Young Kim
Grace Facio
Lynda Roman
Susan Jeffers
P304
P356
10.1016/J.YGYNO.2004.02.007
P407
P577
2004-05-01T00:00:00Z